基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 RO4987655(CH4987655) 化合物 RO4987655
  • 化合物 RO4987655|T5412|TargetMol

化合物 RO4987655|T5412|TargetMol

RO4987655
874101-00-5
427 1mg 起订
619 2mg 起订
993 5mg 起订
上海 更新日期:2024-09-29

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
化合物 RO4987655
英文名称:
RO4987655
CAS号:
874101-00-5
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
98.21%
产品类别:
抑制剂
货号:
T5412

Product Introduction

Bioactivity

名称RO4987655
描述RO4987655 (RG7167) is an orally active and highly selective MEK inhibitor (IC50: 5.2 nM for MEK1/MEK2).
细胞实验Cells were treated with various concentrations of RO4987655 for 72 h in 96-well plates and viable cells were quantified with Cell Counting Kit-8. For Western blotting, cells were treated with RO4987655 for indicated periods and lysed with cell lysis buffer containing a protease inhibitor cocktail, phosphatase inhibitor cocktails 2 and 3, and 1 mM PMSF. For detection of protein bands, the following were used as primary antibodies: pEGFR, EGFR, pMKK4, MKK4, pAKT, AKT, pERK, ERK, pMEK1/2, MEK, Cyclin D1, and actin. All protein bands were visualized with secondary antibodies labeled with HRP and ECL system by using ImageQuant LAS 4000 [2].
动物实验A time interval of 20 to 24 h was used between daily RO4987655 administration and completion of PET imaging for each tumor-bearing mouse and for each PET imaging time point (day 0, 1, 3 and 9). Mice were fasted for 6 to 8 h prior to start of the imaging session. [18F] FDG (7 to 8 MBq per mouse, maximum volume of 200 μL) was administered to awake, warmed (37°C) mice by a bolus injection via the tail vein. Forty to sixty minutes after the tracer injection, the mice were administered with isoflurane, controlled by an E-Z anesthesia vaporizer. The mice were placed on a heated pad (37°C) on the camera bed, with most of the body volume in the field of view (7.68 cm). Emission data were collected for 20 min in list mode with a microPET Focus 120 scanner. Maximum standardized uptake values (SUVmax) of [18F] FDG uptake in the tumor were calculated and normalized to the administered activity (MBq/body weight, g). The drug effect on tumor metabolism was estimated as%SUVmax change to day 0 (baseline) [2].
体外活性CH4987655 (RO4987655) 强效抑制有丝分裂原激活蛋白激酶信号通路的激活及肿瘤细胞生长,在体外对MEK1/2的抑制IC50为5.2 nmol/L [1]。在NCI-H2122细胞中,RO4987655在从0.1到1.0 μM的剂量范围内,治疗开始后2小时就已显著抑制pERK1/2。RO4987655以剂量依赖性方式抑制NCI-H2122细胞的增殖,IC50值为0.0065 μM [2]。
体内活性在剂量范围研究中,以RO4987655 5.0 mg/kg治疗,导致第1天FDG摄取显著减少。随后每天给予RO4987655,2.5 mg/kg治疗,并在药物给予的第1、3和9天进行PET检查。最大降幅观察于第1天,随后第3天略有反弹。之后效果至第9天治疗保持平稳[2]。0.5、1、2、3和4 mg的剂量安全且耐受性良好。共报告26例不良事件(n=15),其中21例轻微,5例中度,无严重不良事件。1 mg剂量下一名受试者出现中度不良事件(自主神经系统失衡),而在4 mg剂量下,三名受试者经历了中度不良事件(腹泻、腹痛、自主神经系统和痤疮)[3]。
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度DMSO : 35 mg/mL (61.92 mM)
关键字RG 7167 | CH 4987655 | RO 4987655 | MAPKK | RO4987655 | MEK | Mitogen-activated protein kinase kinase | MAP2K | RO-4987655 | Inhibitor | inhibit | RG-7167 | CH-4987655
相关产品Lidocaine hydrochloride | Pelitinib | PD 198306 | Lidocaine | Honokiol | Refametinib R enantiomer | PD184161 | U0126-EtOH | Selumetinib | Refametinib | Binimetinib | Trametinib
相关库抑制剂库 | 经典已知活性库 | 抗癌活性化合物库 | 已知活性化合物库 | 激酶抑制剂库 | 高选择性抑制剂库 | 药物功能重定位化合物库 | 疼痛相关化合物库 | 抗癌临床化合物库 | 抗癌药物库
RG7167|||CH4987655|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

化合物 RO4987655相关厂家报价 更多

内容声明
拨打电话 立即询价